Antiviral treatment strategies based on gene silencing and genome editing

Antiviral treatment strategies based on gene silencing and genome editing

Online publication: 21/04/2017 Printed publication: 1 June 2017 Journal: Current Opinion in Virology

Abstract:

The ability of some viruses to establish latently infected chronic reservoirs that escape to immune control becomes a major roadblock that impedes the cure of these infections. Therefore, new alternatives are needed to pursuit the eradication of viral persistent infections. Gene silencing technologies are in constant evolution and provide an outstanding sequence specificity that allows targeting any coding sequence of interest. Here we provide an overview of the development of gene silencing technologies ranging from initially RNA interference to the recently developed CRISPR/Cas9 and their potential as new antiviral strategies focusing on the eradication of HIV.

Authors: Badia R, Ballana E, Esté JA, Riveira-Muñoz E

Subscribe to our newsletter

Back to Top
Irsi Caixa

Promoted by:

'La Caixa' Foundation Generalitat de Catalunya - Departament de Salut

 

HR Excellence in Research

Member of:

Cerca

In cooperation with: